tiragolumab
Showing 26 - 39 of 39
Squamous Cell Carcinoma of the Head and Neck Trial in Duarte, Portland (Atezolizumab, Tiragolumab, Immune-modulating
Recruiting
- Squamous Cell Carcinoma of the Head and Neck
- Atezolizumab
- +4 more
-
Duarte, California
- +1 more
Aug 16, 2022
Cervical Cancer Trial in Worldwide (Tiragolumab, Atezolizumab)
Active, not recruiting
- Cervical Cancer
- Tiragolumab
- Atezolizumab
-
Phoenix, Arizona
- +65 more
Jan 19, 2023
Squamous Cell Carcinoma of Head and Neck Trial in Worldwide (Atezolizumab, Tiragolumab, Placebo)
Active, not recruiting
- Squamous Cell Carcinoma of Head and Neck
- Atezolizumab
- +2 more
-
La Jolla, California
- +57 more
May 18, 2022
NSCLC (NSCLC) Trial in Worldwide (Tiragolumab, Atezolizumab, Pemetrexed)
Recruiting
- Non-small Cell Lung Cancer (NSCLC)
- Tiragolumab
- +6 more
-
Jonesboro, Arkansas
- +138 more
Jan 17, 2023
Gastric and Gastroesophageal Junction Carcinoma Trial in China (Atezolizumab, Capecitabine, Oxaliplatin)
Recruiting
- Gastric and Gastroesophageal Junction Carcinoma
- Atezolizumab
- +3 more
-
Beijing City, China
- +11 more
Jul 29, 2022
Small Cell Lung Cancer Trial in Worldwide (Tiragolumab, Atezolizumab, Carboplatin)
Active, not recruiting
- Small Cell Lung Cancer
- Tiragolumab
- +4 more
-
Lone Tree, Colorado
- +123 more
Dec 21, 2022
Esophageal Squamous Cell Carcinoma Trial in Worldwide (Tiragolumab, Atezolizumab, Tiragolumab Matching Placebo)
Recruiting
- Esophageal Squamous Cell Carcinoma
- Tiragolumab
- +3 more
-
Corona, California
- +230 more
Jan 13, 2023
Endometrial Cancer Trial in United States (Atezolizumab - 28 Day Cycle, Bevacizumab, Ipatasertib)
Recruiting
- Endometrial Cancer
- Atezolizumab - 28 Day Cycle
- +6 more
-
Duarte, California
- +13 more
Jun 8, 2022
NSCLC Trial in Worldwide (Atezolizumab, Tiragolumab, Matching Placebo)
Recruiting
- Non-Small Cell Lung Cancer
- Atezolizumab
- +2 more
-
Littleton, Colorado
- +175 more
Jan 12, 2023
NSCLC (NSCLC) Trial in Worldwide (Atezolizumab, Tiragolumab, Durvalumab)
Recruiting
- Non-small Cell Lung Cancer (NSCLC)
- Atezolizumab
- +2 more
-
Tempe, Arizona
- +254 more
Aug 8, 2022
Metastatic Colorectal Cancer Trial in Worldwide (Inavolisib, Bevacizumab, Cetuximab)
Recruiting
- Metastatic Colorectal Cancer
- Inavolisib
- +7 more
-
Birmingham, Alabama
- +36 more
Dec 29, 2022
Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma Trial in Worldwide (5-Fluorouracil
Recruiting
- Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma
- 5-Fluorouracil (5-FU)
- +11 more
-
Scottsdale, Arizona
- +41 more
Jan 19, 2023
Advanced Unresectable or Metastatic Solid Malignancy Trial in United States (Entrectinib, Inavolisib, Alectinib)
Recruiting
- Advanced Unresectable or Metastatic Solid Malignancy
- Entrectinib
- +11 more
-
Birmingham, Alabama
- +50 more
Aug 10, 2022